Bailard »

Inozyme Pharma shares owned by Bailard

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Bailard

Quarter filed Position value Share count Share price at filing
2024-06-30 $108k 24k 4.46
2024-03-31 $186k 24k 7.66

More positions owned by Bailard

Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Vanguard World Inf Tech Etf (VGT)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Msci Eafe (IEFA)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Amazon (AMZN)
Gilead Sciences (GILD)
Visa Com Cl A (V)

View all positions for Bailard

Top funds holding Inozyme Pharma

Adage Capital Partners GP
Pivotal bioVenture Partners Investment Advisor
Sofinnova Ventures
Eventide Asset Management
Rock Springs Capital Management
Samlyn Capital
BlackRock
Affinity Asset Advisors
Vanguard Group
NEA Management Company
FMR
Millennium Management
Samsara BioCapital
Sphera Funds Management
Geode Capital Management

View all funds holding Inozyme Pharma